Minotab (Minocycline)

Minocycline, the active ingredient in Minotab, is a tetracycline antibiotic presented as a tablet for oral use. It treats bacterial infections such as acne vulgaris, skin and soft‑tissue infections, respiratory tract infections and urinary tract infections in adults and adolescents. It is indicated for patients requiring systemic antibacterial therapy and is commonly prescribed by dermatologists, internists and primary care physicians.

GNH USA supplies Minotab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Minocycline is used to treat bacterial infections affecting several organ systems. - Acne vulgaris: reduces inflammatory lesions and bacterial colonisation of the skin. - Skin and soft‑tissue infections: eradicates susceptible bacteria causing cellulitis, abscesses and wound infections. - Respiratory tract infections: treats community‑acquired pneumonia, sinusitis and bronchitis caused by susceptible organisms. - Urinary tract infections: clears uncomplicated UTIs caused by susceptible Gram‑negative and Gram‑positive bacteria.

Common Side Effects: - Nausea: mild to moderate stomach upset occurring shortly after dosing. - Photosensitivity: increased skin sensitivity to sunlight, leading to sunburn‑like reactions. - Dizziness: transient light‑headedness, especially when standing quickly. - Headache: mild to moderate pain often resolving without intervention.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Drug‑induced hepatitis: elevated liver enzymes and possible jaundice. - Pseudotumor cerebri: increased intracranial pressure presenting with headache and visual disturbances. - Anaphylaxis: rapid onset of allergic reaction with airway compromise. - Severe vestibular toxicity: persistent vertigo and balance disturbances.

Before prescribing Minotab, clinicians should consider the following precautions: - Renal function: adjust use in patients with impaired kidney function. - Hepatic function: monitor liver enzymes during prolonged therapy. - Hypersensitivity: avoid in individuals with known allergy to tetracyclines. - Pregnancy: use only if potential benefit outweighs unknown fetal risk. - Concomitant photosensitising agents: counsel patients to limit sun exposure. - Store below 25°C: keep in the original pack, protect from moisture.

Minotab may interact with several medicines; the following categories guide clinical monitoring. Major Interactions (Avoid): - Antacids containing aluminium or magnesium: reduce minocycline absorption. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Isotretinoin: combined use can increase risk of intracranial hypertension. Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be reduced, advise backup contraception. - Penicillins: possible antagonistic antibacterial effect. - Phenytoin: may lower phenytoin plasma concentrations, requiring dose adjustment.